Liposomal mr contrast agents

Journal of Liposome Research

Volumn 4, Issue 2, 1994, Pages 811-834

  Fritz, Thomas ^a   Wu, Guanli ^a   Shen, Dekang ^a   Kulik, Brenda ^a   New, Terri ^a   Crowell, Michelle ^a   Wilke, Norbert ^b   Unger, Evan ^c  

^a ImaRx Therapeutics Inc   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; CONTRAST MEDIUM; EDETIC ACID; GADOLINIUM PENTETATE; LIPOSOME; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; DOSE RESPONSE; DRUG CLEARANCE; DRUG FORMULATION; DRUG SYNTHESIS; HEART MUSCLE PERFUSION; KUPFFER CELL; LIVER METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; TISSUE SPECIFICITY;

EID: 0028110873     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109409018601     Document Type: Article

References (36)

1. Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes
2. Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging
3. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: Targeted MRI contrast enhancement agents for the liver
4. In vivo relaxometry using a nitroxide-liposome system
5. A liposomal MRI contrast agent: Phosphatidylethanolamine - DTPA
6. NMR and ESR study of liposome delivery of Mn2+ to murine liver
7. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents
8. Permeability of liposomal membranes to water: Results from the magnetic field dependence of Tl of solvent protons in suspensions of vesicles with entrapped paramagnetic ions
9. The design of liposomal paramagnetic MR agents: Effect of vesical size upon the relaxivity of surface-incorporated lipophilic chelates
10. Gadolinium-DTPA liposomes as a potential MRI contrast agent
11. Liposomal Gd-DTPA: Effect of encapsulation on enhancement of hepatoma model by MRI
12. Hepatic metastases: Liposomal Gd-DTPA-enhanced MR imaging
13. Biodistribution and clearance of liposomal gadolinium-DTPA
14. Clearance of liposomal gadolinium: In vivo decomplexation
15. Detailed toxicity studies of liposomal Gadolinium-DTPA
16. Manganese-based paramagnetic liposomes: Comparative approaches
17. Manganese based liposomes: Comparative approaches
18. Status of liposomes as MR contrast agents
19. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
20. Contrast enhanced NMR imaging: animal studies using gadolinium-DTPA complex
21. The effect of lipid composition on the relaxivity of Gd-DTPA entrapped in lipid vesicles of defined size
22. Metallothionein ras (T24) fusion gene modulates expression of two genes associated with in vivo liver cancer in rat liver cells
23. Regulation of a metallothionein-rasT24 fusion gene by zinc results in graded alterations in cell morphology and growth
24. Contrast enhanced myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia
25. Liposomal Gd-DTPA: preparation and characterization of relaxivity
26. Clearance and biodistribution studies on Mn-EDTA-DDP liposomes (memsomes): a new class of liver MR contrast agents
27. Hepatic contrast agents for computed tomography: high atomic number particulate material
28. Lethal doses of solid and liquid compounds: Laboratory animals
29. Relaxivity and binding of Mn2+ ions in solutions of phosphatidylserine vesicles
30. Asialofetuin-coupled monocrystalline iron oxide as an asialoglyprotein receptor MR imaging agent (abstr)
31. Fe-PGDF as a contrast agent for the biliary system and small intestine: MRI in dogs (abstr)
32. Imaging characteristics of Gd-EOB-DTPA as a liver-specific contrast agent for MRI in the rat (abstr)
33. The influence of tumor histology and hepatocellular injury on the enhanced detection of liver tumors by Gd-BOPTA/Dimeg (abstr)
34. Manganese dipyridoxyl diphosphate: effect of dose, time, and pulse sequence on hepatic enhancement in rats